BILLERICA, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the full ...
BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...
Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
Despite production difficulties stemming from a recall of its customized knee implants, ConforMIS beat analysts’ estimates for revenue. Despite production difficulties stemming from a recall of its ...
Patients do not conform to a one-size-fits-all implant model, especially when it comes to knee replacements. Off-the-shelf implants often leave room for improvement in terms of fit and comfort because ...
BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal ® ...
DURHAM, N.C. and BILLERICA, Mass., June 22, 2023 (GLOBE NEWSWIRE) -- restor3d, Inc. and Conformis, Inc. (NASDAQ: CFMS) announced today that they have entered into a definitive merger agreement under ...
Ivan Hildreth's knees had gotten so bad he couldn't walk up a flight of stairs without a lot of pain and effort. He had resisted getting his knees replaced, but his wife finally convinced him last ...
Good morning, and welcome to the First Quarter 2023 Earnings Conference Call for Conformis, Incorporated. My name is Tanya, and I will be your conference operator today. All lines have been placed on ...
Please provide your email address to receive an email when new articles are posted on . restor3d Inc. has announced the completed acquisition of Conformis Inc. Conformis stock was removed from trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results